Press Releases

LONDON, Aug. 20, 2019 /PRNewswire/ -- Today sees the launch of a strategic new revenue cycle partnership. Powered by Clinithink's ENRICH platform and TrustHCS' renowned reputation in clinical documentation improvement (CDI) and health information management (HIM), the combined offering enables TrustHCS to significantly reduce the costs associated with 2nd

FORT WORTH, Texas, Aug. 20, 2019 /PRNewswire/ -- International Love Scout, the internet's most authoritative source on international dating, is launching romance tours sp

RICHMOND, Va., Aug. 20, 2019 /PRNewswire/ -- Intimate Wellness Institute – the largest and most comprehensive network of dedicated female wellness practitioners – is proud to introduce Cliovana to their offerings of evidence-based energy treatments to address female sexual health concerns.Truly satisfying sex is an important part of a woman's ove

TIJUANA, Mexico, Aug. 20, 2019 /PRNewswire/ -- Today, Mexico Bariatric Center®

NEW YORK, Aug. 20, 2019 /PRNewswire/ -- The Mesothelioma Victims Center says, "We are now offering to assist a mechanic, a machinist or any type of skilled trades worker

SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-A, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion

Customers can now purchase custom Veterans Cannabis Project pre-rolls to support veterans' access to cannabis PORTLAND, Ore., Aug. 20, 2019 /PRNewswire/ -- Curaleaf, a leading vertically

NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) and Chemveda Life Sciences are very pleased to announce the successful chemical synthesis of a unique natural compound that has shown remarkable efficacy as a potential chemotherapy for the treatment of liver cancer. This is a significant advancement for Q BioMed's portfolio asset "U

SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the results from EPOCH 2, a Phase 3 study of the investigational agent HTX-011 in

FAIRLAWN, Ohio, Aug. 20, 2019 /PRNewswire/ -- Two surgical innovations developed by Crystal Clinic Orthopaedic Center are advancing care for patients with anterior cruciate ligament (ACL) injuries and cartilage loss in joints through the use of biologic therapy. These advancements promote the body's natural ability to heal, and provide a simpler, more cos